Search results
Why Markets Must Beware Powell’s Comments on Fed Rate Hikes, and 5 Other Things to Know Today
Barrons.com· 6 days agoNovo Nordisk hikes guidance as sales of weight-loss drugs surge, Qualcomm profit lifted amid high...
Earnings call: CVS Health faces challenges, revises 2024 EPS guidance By Investing.com
Investing.com· 7 days agoThe company announced a revision of its full-year 2024 guidance for adjusted EPS to at least $7,...
Q1 2024 Alignment Healthcare Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoA top line outperformance was primarily a function of higher health plan membership as our superior value proposition continued to resonate in the market. Adjusted gross profit ...
Earnings call: Assertio Holdings reports growth and CEO search progress By Investing.com
Investing.com· 1 day agoThe company highlighted a significant 32% quarter-over-quarter growth in Rolvedon sales and the...
Earnings call: Assertio Holdings reports growth and CEO search progress
Investing.com· 1 day agoThe company highlighted a significant 32% quarter-over-quarter growth in Rolvedon sales and the...
Assertio Holdings, Inc. (NASDAQ:ASRT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoAssertio Holdings, Inc. (NASDAQ:ASRT) Q1 2024 Earnings Call Transcript May 6, 2024 Assertio...
CMS Issues Draft Guidance on Inflation Reduction Act (IRA) Drug Price Negotiation Program for 2027 |...
JD Supra· 1 day agoCMS is seeking comment on this draft guidance for the drug price negotiation process for IPAY 2027, for which the next 15 Part D drugs will be selected by February 1, 2025. CMS also issued a ...